It is the most widely used retinal prosthesis worldwide, with over 250 patients estimated to have undergone implantation to date. With the argus ii retinal prosthesis by paul hahn, md, phd. Second sight announces first agerelated macular degeneration. Intraoperative oct imaging of the argus ii retinal. The argus ii system has already been studied in completely blind patients with retinitis pigmentosa rp. Retinitis pigmentosa rp is a group of heterogeneous inherited retinal degenerative disorders characterized by progressive rod and cone. Second sight announces positive fiveyear data from argus. A clinical trial enrolling 5 subjects with severe agerelated macular degeneration is currently. Agerelated macular degeneration patient receives bionic eye.
Costeffectiveness of the argus ii retinal prosthesis. Intraoperative oct imaging of the argus ii retinal prosthesis system article in ophthalmic surgery lasers and imaging retina 4711. Retinitis pigmentosa rp is a hereditary genetic disease causing bilateral retinal degeneration. Practical concepts with the argus ii retinal prosthesis. May 16, 2017 the argus ii is the only retinal implant to have been approved for sale in the european economic area, the us, and canada. Currently marketed implants such as second sights argus ii. To date, argus ii artificial retina is implanted in four patients in iran.
The device may help adults with rp who have lost the ability to perceive shapes and movement to be more mobile and to perform daytoday activities. The 60electrode array is surgically implanted on the epiretinal side of the retina fig. Fda approval for argus ii retinal prosthesis system. The argus ii retinal prosthesis system eyecare tomorrow. In early testing, a bioengineered retinal implant appears to be safe for use in humans and may be effective in treating vision loss caused by one type of macular degeneration. Is there any published data about the argus ii results. Rp is a leading cause of blindness resulting in incurable visual impairment and drastic reduction in the quality of life of the patients. While competing retinal implants generally target rare conditions involving. As such it has entered the commercial market as a treatment for patients with profound vision loss from endstage outer retinal disease, predominantly retinitis pigmentosa. Pracical reina practical concepts with the argus ii.
Argus ii retinal prosthesis system dry amd feasibility. The argus ii retinal prosthesis bionic eye receives. Image data from an external camera is wirelessly transmitted to the implant which stimulates electrodes in an array on the retina to produce visual percepts. Currently, it has been implanted in more than 70 patients.
A third epiretinal device, epiret, has been developed and progressed to clinical testing in six patients. Michael jumper, md, spoke with mark humayun about the argus ii and its practical implications for asrs members and patients. Jul 22, 2015 agerelated macular degeneration patient receives bionic eye transplant by chris wood. After more than 20 years of research and development, second sight medical products announced that its argus ii retinal prosthesis system has received u. Retinal prostheses for restoration of sight to patients blinded by retinal degeneration are being.
We extend an invitation to readers to submit pearls for publication in retina today. Another epiretinal device, the learning retinal implant, has been developed by iip technologies gmbh, and has begun to be evaluated in clinical trials. A retinal implant that is more effective against blindness duration. Argus ii archives retina specialist fairfax, virginia. Retinal implants could restore sight to more than 2 million people human trials are on the horizon for the potentially lifechanging tech. The argus ii retinal prosthesis system is one such artificial vision device. The purpose of this study is to test the argus ii retinal prosthesis system in patients with severe agerelated macular degeneration amd. The costeffectiveness of the argus ii retinal prosthesis in. The argus ii, a retinal implant intended for patients. Feb 29, 2016 emory eye center offers argus ii retinal prosthesis system duration. Humayun, director of the usc institute for biomedical therapeutics and codirector. Argus ii is the worlds first evercommercial implant intended to restore some vision in the. On august 15, 20, second sight medical products, inc. For patients with retinitis pigmentosa rp, you may qualify for this procedure that partially restores vision continue reading.
The argus i artificial retina model has already undergone human implant tests. Humayun, md, phd, who has devoted 25 years to its research and development. The argus ii retinal prosthesis system second sight medical products, inc. The argus ii retinal implant, manufactured by second sight medical products received market approval in the us in feb 20 and in europe in feb 2011, becoming the first approved implant. Agerelated macular degeneration patient receives bionic eye transplant by chris wood. Retinal implant for macular degeneration tested in first. The argus ii retinal prosthesis system second sight medical products is the first prosthetic vision device to obtain regulatory approval in both europe and the usa. Implanting the argus ii is a well established surgery, typically taking only a few hours. Recently, usc roski eye institute patient, terry byland, became the first person in the world to have two retinal implants. Jan 14, 2015 collins was later referred to emorys retina service, and just this year received a letter indicating he might be a good candidate for a new groundbreaking procedure for those patients who are blind from rp. Second sight announces positive fiveyear data from argus ii retinal prosthesis system. Surgical pearls for implantation of the argus ii retinal.
Retinal implants could restore sight to more than 2. Renowned vitreoretinal surgeon, njretinas paul hahn, md, phd has brought a cuttingedge, fdaapproved implant procedure, the argus ii retina prosthesis system, to new jersey. Adapted surgical procedure for argus ii retinal implantation. Argus ii retinal implant successfully completes clinical trial. Correct coding argus ii retinal prosthesis system noridian. As coinventors, they converged the concepts of both bioengineering and medicine to develop the argus ii retinal prosthesis system, which is a medical. Argus ii retinal implant bionic eye retinal prosthesis system. Our study shows that this unique stem cellbased retinal implant thus far is welltolerated, and preliminary results suggest it may help people with advanced dry agerelated macular degeneration, said coauthor and lead inventor of the implant dr. The argus ii retinal prosthesis system is one such artificial vision device approved for patients with rp. The functional performance of the argus ii retinal prosthesis. Study pioneers implantation of argus ii in patients with advanced dry. It is used as a visual prosthesis to improve the vision of people with severe cases of retinitis pigmentosa. Argus retinal prosthesis, also known as a bionic eye, is an electronic retinal implant manufactured by the american company second sight medical products. The device is designed to replicate the function of photoreceptors in converting visual information into electrical neural signals in patients with profound visual loss secondary to degenerative retinal disease.
Retina posted 8920 the implantation procedure is shown in this video. He is using a retinal implant which converts video images from a. A pilot study evaluating its use in advanced dry agerelated macular degeneration is currently underway, and this device may also prove to benefit other. The argus ii is the only retinal implant to have been approved for sale in the european economic area, the us, and canada. Those currently in or near human testing include boston retinal implant project, or brip boston, a cofounder of the field along with second sight sylmar, calif. The argus ii was the first retinal implant to receive ce marking, and the only implant granted an fda approval as a humanitarian use device. Sep 05, 2018 in addition to argus ii retinal implant, the iris 2 pixium and alphaams retina implant devices have received the eu ce mark hornig et al. It is attached to the retina over the macula with a retinal tack. A retinal implant system that is capable of restoring some sight to adults who have lost their vision due to retinitis pigmentosa. The argus ii device second sight medical products is the only fdaapproved epiretinal implant at this time. A pilot study evaluating its use in advanced dry agerelated macular degeneration is currently underway, and this device may also prove to benefit other retinal degenerations.
During months of followup testing, kulik will train her brain to see in a new way, interpreting the signals sent by argus ii. The argus ii, a retinal implant intended for patients with degenerative eye disorders, has successfully completed a threeyear clinical trial. Argus ii received approval from the us fda on april 14, 20 fda approval. Fda approves first retinal implant scientific american.
The argus ii retinal prosthesis system sciencedirect. Research is ongoing, and has documented improvement in visual acuity best achieved 201,262 and task completion with the 60electrode array. Aug 19, 20 on august 15, 20, second sight medical products, inc. Second sight announces first agerelated macular degeneration patient receives the argus ii retinal prosthesis system as part of groundbreaking study. Feb 24, 2016 a retinal implant system that is capable of restoring some sight to adults who have lost their vision due to retinitis pigmentosa. The argus ii epiretinal prosthesis second sight medical products inc. The image shown in f is what argus ii was able to capture for lisa that day. The procedure is performed by an experienced retinal surgeon, with second sight technicians available for your support. Apr 12, 2018 in early testing, a bioengineered retinal implant appears to be safe for use in humans and may be effective in treating vision loss caused by one type of macular degeneration. Argus ii retinal prosthesis implantation using three. The first recipient with dry amd, ray flynn, was fitted with the implant june 16, 2015. Retinal implants implant uses electrical stimulation to bypass defective photoreceptors and stimulate remaining viable retinal cells. The argus ii retinal prosthesis system is a visual prosthesis that. Retina today surgical pearls for implantation of the argus.
The fdas green light for second sights argus ii retinal prosthesis system gives hope to. Mar 15, 20 after more than 20 years of research and development, second sight medical products announced that its argus ii retinal prosthesis system has received u. When daughter opal read the letter to him, they discussed it thoroughly before deciding that he, indeed, would like to have an evaluation. Apr 14, 2014 retinitis pigmentosa rp is a hereditary genetic disease causing bilateral retinal degeneration. Four more patients with dry macular degeneration will receive a retinal implant called the argus ii retinal prosthesis. The argus ii retinal prosthesis aims to restore vision in patients with profound vision loss due to endstage retinal degenerative diseases such as retinitis pigmentosa. The replacement parts must be billed to the ab mac. Apr 06, 2018 our study shows that this unique stem cellbased retinal implant thus far is welltolerated, and preliminary results suggest it may help people with advanced dry agerelated macular degeneration, said coauthor and lead inventor of the implant dr. Enrollment has been completed in a feasibility trial to test the safety and utility of the argus ii in individuals with dry agerelated macular degeneration.
In addition to argus ii retinal implant, the iris 2 pixium and alphaams retina implant devices have received the eu ce mark hornig et al. The argus ii is the first and only retinal implant to have both approvals, and is the only system to have. Fda approves worlds first artificial retina the american. Argus ii is the worlds first evercommercial implant. Copenhagen the argus ii retinal prosthesis system implanted in patients with dry agerelated macular degeneration proved effective in. The argus ii retinal prosthesis system second sight medical products, sylmar, ca is the first and only retinal prosthesis to have authorities approvals for commercialization in the european economic area, the united states, and canada. The argus ii retinal prosthesis system argus ii second sight medical products, inc, sylmar, ca was approved by the food and drug administration in 20 for patients with retinitis pigmentosa and visual acuity of bare light perception or worse. In 2002, argus i, the first iteration of the device, which had 16 microelectrodes, was tested on human subjects who were enrolled in a phase 1 clinical trial. Today, a considerable number of patients are using argus ii retinal prosthesis to regain some functional vision assisting them to make their way in the world.
Agerelated macular degeneration patient receives bionic. Argus ii invention of the worlds first fdaapproved artificial. Once implanted, the argus ii implant sits in and around the back of the eye and is not visible to others. Second sight announces record number of argus ii retinal. The argus ii retinal prosthesis system njretinanjretina. Jul 22, 2015 second sight announces first agerelated macular degeneration patient receives the argus ii retinal prosthesis system as part of groundbreaking study. The argus ii retinal implant, manufactured by second sight medical products. Retinal implant technologies are just emerging, and the argus ii is currently marketed as a complementary device to the long cane and guide dog for complex tasks, such as orientation and mobility.
In subjects with agerelated macular degeneration, who may have intact peripheral vision, retinal implants could result in a hybrid form of vision. The costeffectiveness of the argus ii retinal prosthesis. Argus ii is the worlds first evercommercial implant intended to. These external replacement parts are not billable to the dme mac even if the device is being used in the home. Retinal diseases like, agerelated macular degeneration and retinitis pigmentosa decrease vision by destroying the lightsensitive photoreceptor cells in the retina. Intraoperative oct imaging of the argus ii retinal prosthesis. This is a gamechanger in sightaffecting diseases, that represents a huge step forward for the field and for these patients who were without any. In this issue of retina today, marco mura, md, and giulio bamonte, md, discuss pearls for implantation of the argus ii retinal prosthesis system second sight medical products.
Argus ii clinical trials recruited patients with retinitis pigmentosa or other outer retinal degeneration with bare or no light perception logmar 2. This unique arrangement allows our patients to receive more comprehensive care at the same location and avoid the anxiety of referring you outside to a new doctor, staff and. The argus ii retinal prosthesis system, built by secondsight, is designed to stimulate a. Sep 22, 2016 argus ii retinal prosthesis system correct coding. As a retina specialist, i provide retinal services within different ophthalmology practices in the northern virginia area, including. Dec 08, 2015 the argus ii was the first retinal implant to receive ce marking, and the only implant granted an fda approval as a humanitarian use device. The argus ii retinal prosthesis system was the first of its kind to receive regulatory approval for commercial use in europe and the usa. Fda approval for marketing under this indication was granted on february, 20. Second sights argus ii retinal prosthesis system gives hope to those blinded by a rare genetic eye condition called advanced retinitis pigmentosa, which. The development of a retinal implant was the brainchild of asrs executive committee and board member mark s. It elicits visual percepts by electrically stimulating surviving neurons. Second sight has developed, and now manufactures and markets, the argus ii retinal prosthesis system. The device is a prosthesis, a retinal implant, that can provide stimulation of the retina to induce visual perception in blind individuals.
1274 856 1622 718 361 800 1094 1198 1037 1241 570 382 1223 436 1600 418 870 785 21 528 1130 1394 373 372 835 281 1314 1342 415 907 1175